This was the stock's third consecutive day of losses.

Some people are facing delays in filling prescriptions for the glucose sensor. Abbott expects to resolve the problem soon.

The "Global Neurology Devices Market 2024 Edition: Market Size, Trends, Opportunities and Forecast by Product Type, Treatment Stage, End-Users, Region, By Country: 2020-2030" report has been added to ...

The stock's fall snapped a two-day winning streak.

O'Melveny & Myers is defending Abbott Laboratories in a pending class action against the company and two other co-defendants, ...

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Medtronic (MDT – Research Report), with a ...

In a report released yesterday, Larry Biegelsen from Wells Fargo maintained a Buy rating on Abbott Laboratories (ABT – Research Report), ...

LAS VEGAS — Republican Texas Gov. Greg Abbott has been in more than a few debates during his decades-long political career. Abbott won three terms as state attorney general before winning ...

Texas Governor Greg Abbott's migrant busing program has reportedly cost taxpayers $221 million to transport nearly scores of asylum seekers to Democrat-run states north of the U.S.-Mexico border ...

The Department of Justice announced an investigation into Abbott Laboratories' Michigan plant which was at center of a nationwide formula shortage in 2022. Abbott is recalling several of its ready ...

Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the ...